WS-11 - Outcome Measurements for External Comparator Arms: New Opportunities for Epidemiology Methods Application and Development
Location: WS-11
Methods in Pharmacoepidemiology
Monday, Aug 23rd
10:00 AM – 11:30 AM US Eastern Time
WS-13 - Polypharmacy: Problems and Solutions for Its Methodologic Challenges in Real-world Data
Location: WS-13
Methods in Pharmacoepidemiology
Monday, Aug 23rd
11:45 AM – 1:30 PM US Eastern Time
OP-9A - A New Method to Estimate the Total Cohort Size for Patient Recruitment in self-controlled Case Series Study
Location: OP-09
Methods in Pharmacoepidemiology
Monday, Aug 23rd
11:45 AM – 1:30 PM US Eastern Time
OP-9B - Sessa Empirical Estimator (SEE): A Data-driven Method for Predicting the Duration of Pharmacological Prescriptions in Secondary Data Sources
Location: OP-09
Methods in Pharmacoepidemiology
Monday, Aug 23rd
11:45 AM – 1:30 PM US Eastern Time
OP-9C - Graphical Representation of an Array of Quantitative Bias Analysis Scenarios for Differential Outcome Misclassification
Location: OP-09
Methods in Pharmacoepidemiology
Monday, Aug 23rd
11:45 AM – 1:30 PM US Eastern Time
OP-9D - The Performance of Different Strategies to Manage Confounding in Cardinality Matching for Medical Device Epidemiology: A Simulation Study
Location: OP-09
Methods in Pharmacoepidemiology
Monday, Aug 23rd
11:45 AM – 1:30 PM US Eastern Time
OP-9E - Use of Linked Databases for Improved Confounding Control: Considerations for Potential Selection Bias
Location: OP-09
Methods in Pharmacoepidemiology
Monday, Aug 23rd
11:45 AM – 1:30 PM US Eastern Time
OP-9F - A Systematic Approach Towards Missing Lab Data in Electronic Health Records: A Case Study in Non-small Cell Lung Cancer and Multiple Myeloma
Location: OP-09
Methods in Pharmacoepidemiology
Monday, Aug 23rd
1:45 PM – 3:30 PM US Eastern Time
OP-24A - Using Randomized Trial Data to Estimate Effects of Complex Treatment Regimens in Real-world Patients
Location: OP-24
Methods in Pharmacoepidemiology
Monday, Aug 23rd
1:45 PM – 3:30 PM US Eastern Time
OP-24B - A Plasmode Simulation of Covariate Misclassification and Transportability
Location: OP-24
Methods in Pharmacoepidemiology
Monday, Aug 23rd
1:45 PM – 3:30 PM US Eastern Time
OP-24C - The Effect of the Anticholinergic Properties of Antidepressants on the Incidence of Dementia: A Target Trial Emulation
Location: OP-24
Methods in Pharmacoepidemiology
Monday, Aug 23rd
1:45 PM – 3:30 PM US Eastern Time
OP-24D - Stable Balancing Weights for Unanchored Matching-adjusted Indirect Comparisons and Targeting External Control Arm Estimands
Location: OP-24
Methods in Pharmacoepidemiology
Monday, Aug 23rd
1:45 PM – 3:30 PM US Eastern Time
OP-24E - Linear Mixed Model and Multistate Markov Model to Compare Changes in Clinical Measurements over Time. a Blood Pressure Example
Location: OP-24
Methods in Pharmacoepidemiology
Monday, Aug 23rd
1:45 PM – 3:30 PM US Eastern Time
OP-24F - Rank-based Weighting for Balancing on Median Baseline Characteristics in Matching Adjusted Indirect Comparisons (MAIC)
Location: OP-24
Methods in Pharmacoepidemiology
Monday, Aug 23rd
3:30 PM – 5:00 PM US Eastern Time
WS-04 - COVID-19 Confidential: Enabling Trust in COVID-19 Research with Fit for Purpose Real-world Data
Location: WS-04
Methods in Pharmacoepidemiology
Monday, Aug 23rd
3:30 PM – 5:00 PM US Eastern Time
WS-19 - Triangulating the Truth: State-of-the-art Sensitivity Analyses for Observational Research
Location: WS-19
Methods in Pharmacoepidemiology
Monday, Aug 23rd
5:30 PM – 6:30 PM US Eastern Time
L-1E - Marginal Structural Models with Latent Class Growth Modeling of Time-varying Treatment
Location: L-1
Methods in Pharmacoepidemiology
Monday, Aug 23rd
5:30 PM – 6:30 PM US Eastern Time
L-1F - Residual Bias and Indirect Covariate Balance in an Applied Comparison of Large-scale Propensity Score and Cardinality Matching
Location: L-1
Methods in Pharmacoepidemiology
Monday, Aug 23rd
5:30 PM – 6:30 PM US Eastern Time
L-1G - Characterizing Imbalance in the Tails of the Propensity Score Distribution
Location: L-1
Methods in Pharmacoepidemiology
Monday, Aug 23rd
5:30 PM – 6:30 PM US Eastern Time
L-1H - High-dimensional Propensity Score Approaches in Stata Using the Hdps Suite of Commands
Location: L-1
Methods in Pharmacoepidemiology
Monday, Aug 23rd
6:30 PM – 7:30 PM US Eastern Time
L-2B - Collider Bias in COVID-19 Studies: Explaining the Smoking Paradox
Location: L-2
Methods in Pharmacoepidemiology
Monday, Aug 23rd
6:30 PM – 7:30 PM US Eastern Time
L-2E - Identification and Characterization of Fistulizing Crohn’s Disease in EHR Using Structured and Unstructured Data
Location: L-2
Methods in Pharmacoepidemiology
Monday, Aug 23rd
6:30 PM – 7:30 PM US Eastern Time
L-2F - Validation of Diagnosis Algorithms for Melanoma and Nonmelanoma Skin Cancer Among Patients with Parkinson’s Disease in the United States Medicare Database
Location: L-2
Methods in Pharmacoepidemiology
Monday, Aug 23rd
6:30 PM – 7:30 PM US Eastern Time
L-2G - An Algorithm to Derive Response and Progression Status Based on International Myeloma Working Group Response Criteria for Patients with Multiple Myeloma in a Real-world Database
Location: L-2
Methods in Pharmacoepidemiology
Tuesday, Aug 24th
11:45 AM – 1:15 PM US Eastern Time
WS-01 - A Call for ‘environmental Pharmacoepidemiology’: Medications, Global and Local Environments, and Health Outcomes
Location: WS-01
Methods in Pharmacoepidemiology
Tuesday, Aug 24th
11:45 AM – 1:15 PM US Eastern Time
WS-02 - Believability of Real-world Evidence (RWE) for Informed Regulatory Decisions
Location: WS-02
Methods in Pharmacoepidemiology
Tuesday, Aug 24th
11:45 AM – 1:15 PM US Eastern Time
WS-10 - New Frontiers in Computable Phenotyping for Medical Product Safety Evaluation
Location: WS-10
Methods in Pharmacoepidemiology
Tuesday, Aug 24th
11:45 AM – 1:15 PM US Eastern Time
WS-20 - Using Real-world External Controls to Support Drug Approval: An Interactive Framework Using Oncology Trial and Real-world Data
Location: WS-20
Methods in Pharmacoepidemiology
Tuesday, Aug 24th
1:45 PM – 3:30 PM US Eastern Time
OP-27A - Validity of Electronic Health Records-based Measures for COVID-19 Hospitalization and Severe Outcomes
Location: OP-27
Methods in Pharmacoepidemiology
Tuesday, Aug 24th
1:45 PM – 3:30 PM US Eastern Time
OP-27B - Death Documentation Lag in COVID-19 Electronic Health Record (EHR) Suggests Caution in Near-real-time Analysis
Location: OP-27
Methods in Pharmacoepidemiology
Tuesday, Aug 24th
1:45 PM – 3:30 PM US Eastern Time
OP-27D - Use of an EHR to Inform a Claims-based Algorithm to Categorize Inpatient COVID-19 Severity
Location: OP-27
Methods in Pharmacoepidemiology
Tuesday, Aug 24th
1:45 PM – 3:30 PM US Eastern Time
OP-27E - Categorization of COVID-19 Severity to Determine Mortality Risk
Location: OP-27
Methods in Pharmacoepidemiology
Tuesday, Aug 24th
3:30 PM – 4:45 PM US Eastern Time
SP01D - Trajectories of Oral Budesonide Use in Crohn's Disease Cohort of Tuscan Patients (Italy)
Location: SP01
Methods in Pharmacoepidemiology
Tuesday, Aug 24th
3:30 PM – 4:45 PM US Eastern Time
SP01F - Pharmacological and Epidemiological Considerations While Constructing Drug Treatment Episodes Using Observational Data Retrospectively Collected: A Simulation Study
Location: SP01
Methods in Pharmacoepidemiology
Tuesday, Aug 24th
3:30 PM – 4:45 PM US Eastern Time
SP05D - Lessons Learned in Predicting Gastric Cancer Survival Using Machine Learning
Location: SP05
Methods in Pharmacoepidemiology
Tuesday, Aug 24th
3:30 PM – 4:45 PM US Eastern Time
SP05E - Real World Progression-free Survival in Patients with Advanced or Metastatic Urothelial Cancer Treated with First-line Platinum-based Chemotherapy
Location: SP05
Methods in Pharmacoepidemiology
Tuesday, Aug 24th
3:30 PM – 4:45 PM US Eastern Time
SP06B - Misclassification of Obesity in Claims Data – Are Assumptions About Non-differential Misclassification Warranted?
Location: SP06
Methods in Pharmacoepidemiology
Tuesday, Aug 24th
3:30 PM – 4:45 PM US Eastern Time
SP06E - Use of Negative Control Outcomes to Detect Mismeasured Confounders in Administrative Data
Location: SP06
Methods in Pharmacoepidemiology
Tuesday, Aug 24th
3:30 PM – 4:45 PM US Eastern Time
SP06H - Simulation-based Evaluation of Index Date Selection Methods with External Controls
Location: SP06
Methods in Pharmacoepidemiology
Tuesday, Aug 24th
3:30 PM – 4:45 PM US Eastern Time
SP07C - Performance of Different Definitions for COVID-19 Infection Across European Databases
Location: SP07
Methods in Pharmacoepidemiology
Tuesday, Aug 24th
3:30 PM – 4:45 PM US Eastern Time
SP07D - Exposure Misclassification in Pharmacoepidemiology: Sources and Relative Impact
Location: SP07
Methods in Pharmacoepidemiology
Tuesday, Aug 24th
3:30 PM – 4:45 PM US Eastern Time
SP07E - Validity of ICD-10 Heart Failure Administrative Codes Among the Elderly in the United States
Location: SP07
Methods in Pharmacoepidemiology
Tuesday, Aug 24th
3:30 PM – 4:45 PM US Eastern Time
SP07F - A Cookbook for Estimating Treatment Duration from Databases of Routinely Collected Electronic Health Data Participating in Multi-source Studies
Location: SP07
Methods in Pharmacoepidemiology
Tuesday, Aug 24th
3:30 PM – 4:45 PM US Eastern Time
SP07G - Validation of Acute Outcomes Among Patients with Type 2 Diabetes Mellitus in the Clinical Practice Research Datalink
Location: SP07
Methods in Pharmacoepidemiology
Tuesday, Aug 24th
3:30 PM – 4:45 PM US Eastern Time
SP08A - Who Will Develop Diabetes? A 5-year Risk Prediction Model for Antidiabetic Treatment Initiation in Individuals with hba1c-defined Prediabetes
Location: SP08
Methods in Pharmacoepidemiology
Tuesday, Aug 24th
3:30 PM – 4:45 PM US Eastern Time
SP08D - Use of a Mobile App to Capture Supplemental Health Information During Pregnancy: Implications for Clinical Research
Location: SP08
Methods in Pharmacoepidemiology
Tuesday, Aug 24th
3:30 PM – 4:45 PM US Eastern Time
SP08F - Development and Validation of Real-world Prediction Models to Identify Individuals with Undiagnosed NASH
Location: SP08
Methods in Pharmacoepidemiology
Tuesday, Aug 24th
5:15 PM – 6:30 PM US Eastern Time
SP17K - Validity of Claims-based Algorithms to Identify Patients with Test-positive Influenza
Location: SP17
Methods in Pharmacoepidemiology
Tuesday, Aug 24th
6:45 PM – 7:45 PM US Eastern Time
L-3D - A New Analytic Tool for Interrupted Times Series Analysis to Assess the Impact of FDA Regulatory Actions
Location: L-3
Methods in Pharmacoepidemiology
Tuesday, Aug 24th
6:45 PM – 7:45 PM US Eastern Time
L-3E - Use of Last Clinical Activity Date in Overall Survival Analysis with Real World Data
Location: L-3
Methods in Pharmacoepidemiology
Tuesday, Aug 24th
6:45 PM – 7:45 PM US Eastern Time
L-3F - Distinguishing Death from Disenrollment in Claims Data Using a Readily Implemented Machine Learning Algorithm
Location: L-3
Methods in Pharmacoepidemiology
Tuesday, Aug 24th
6:45 PM – 7:45 PM US Eastern Time
L-3G - Development and Validation of Case-finding Algorithms to Identify Prosthetic Joint Infections After Total Knee Arthroplasty
Location: L-3
Methods in Pharmacoepidemiology
Wednesday, Aug 25th
10:00 AM – 11:30 AM US Eastern Time
WS-16 - RWE Blueprints: Decoding SPACE, SPIFD, Start-rwe, and Other Tools Promoting Principled Pharmacoepidemiology
Location: WS-16
Methods in Pharmacoepidemiology
Wednesday, Aug 25th
10:00 AM – 11:30 AM US Eastern Time
WS-17 - Selection Matters: Addressing Biases in Linked Clinico-genomic Data Sets
Location: WS-17
Methods in Pharmacoepidemiology
Wednesday, Aug 25th
10:00 AM – 11:30 AM US Eastern Time
WS-18 - Strategies for the Use of Real-world Data to Conduct covid-19-related Pharmacoepidemiology
Location: WS-18
Methods in Pharmacoepidemiology
Wednesday, Aug 25th
11:45 AM – 1:30 PM US Eastern Time
OP-2A - Identifying Active Pregnancies Using ICD-10 Z3A Codes versus Completed Pregnancies Using Outcomes
Location: OP-02
Methods in Pharmacoepidemiology
Wednesday, Aug 25th
11:45 AM – 1:30 PM US Eastern Time
OP-2C - The Impact of Longitudinal Data-completeness of Electronic Health Record (EHR) Data on Prognostic Risk Score Misclassification
Location: OP-02
Methods in Pharmacoepidemiology
Wednesday, Aug 25th
11:45 AM – 1:30 PM US Eastern Time
OP-2E - Improving Methods of Identifying Anaphylaxis for Medical Product Safety Surveillance Using Natural Language Processing and Machine Learning
Location: OP-02
Methods in Pharmacoepidemiology
Wednesday, Aug 25th
11:45 AM – 1:30 PM US Eastern Time
OP-2F - Validation of an Algorithm to Identify Hormonal Contraceptive Exposure in a Large Integrated Health Care Delivery System Database
Location: OP-02
Methods in Pharmacoepidemiology
Wednesday, Aug 25th
11:45 AM – 1:30 PM US Eastern Time
OP-7D - Longitudinal Adherence Trajectories to Biologic Disease Modifying Anti-rheumatic Drugs in Tuscany, Italy
Location: OP-07
Methods in Pharmacoepidemiology
Wednesday, Aug 25th
4:30 PM – 6:00 PM US Eastern Time
OP-1D - Risk of Malignancies in Newly Treated Patients with Disease-modifying Drugs for Multiple Sclerosis: Assessment According to Cohort and Nested-case Control Approaches
Location: OP-01
Methods in Pharmacoepidemiology
Wednesday, Aug 25th
4:30 PM – 6:00 PM US Eastern Time
OP-20A - Evaluating When Effect Estimates Change After Propensity Score Trimming Because of Differing Effect Measure Modifier Distributions
Location: OP-20
Methods in Pharmacoepidemiology
Wednesday, Aug 25th
4:30 PM – 6:00 PM US Eastern Time
OP-20B - Optimization-based Stable Balancing Weights vs. Generalized Boosted Modeling for Propensity Score Weighting
Location: OP-20
Methods in Pharmacoepidemiology
Wednesday, Aug 25th
4:30 PM – 6:00 PM US Eastern Time
OP-20C - Controlling for Differential Regression to the Mean Using Summary Measures of Pre-treatment Laboratory Values in Propensity Scores
Location: OP-20
Methods in Pharmacoepidemiology
Wednesday, Aug 25th
4:30 PM – 6:00 PM US Eastern Time
OP-20E - Disease Risk Score as Alternative to Propensity Score Under Multiple Confounders and High Prevalence of Outcome: A Simulation Study Motivated by the Emergence of Multiple Repurposed Medicines During the COVID-19 Pandemic
Location: OP-20
Methods in Pharmacoepidemiology
Wednesday, Aug 25th
4:30 PM – 6:00 PM US Eastern Time
OP-20F - Cardinality Matching vs Propensity Score Matching in Multiple Sclerosis
